Document is current
Any future updates will be listed below
-
Authors
Murakami, Aya
Koga, Shunsuke
Sekiya, Hiroaki
Nakamura, Masataka
Yakushiji, Yusuke
Dickson, Dennis W.
-
Funding
Funding for this research was provided by:
Fellowships from the Japanese Society of Neurology
the Yukihiko Miyata Memorial Trust for ALS Research
the Katano Foundation
the Research Foundation for Dementia of Osaka
Rainwater Charitable Foundation
Albertson Parkinson's Research Foundation
Spastic Paraplegia Foundation
NIH grants (P30-AG062677)
FAIN (U19AG063911)
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 9 June 2025
First Online: 9 July 2025
Declarations
:
: Brain autopsies were obtained after consent of the legal next-of-kin and studies of this type are considered exempt from human subject research. The Mayo Clinic brain bank operates under protocols approved by the Mayo Clinic Institutional Review Board.
: Not applicable.
: The authors declare no competing interests.
: AM received speaker fees (royalties) from Chugai Pharmaceutical Co., Ltd. And supported by a JSPS KAKENHI Grant-in-Aid for Early-Career Scientists #23K14764. YY received speaker fees (royalties) from the following companies: Daiichi Sankyo Company, Limited; Otsuka Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Kyowa Kirin Co., Ltd.; Alexion Pharmaceuticals, Inc.; EA Pharma Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Kowa Co., Ltd.; Novartis Pharma K.K.; UCB Japan Co., Ltd.; and Eli Lilly Japan K.K. and supported by a JSPS KAKENHI Grant-in-Aid for Scientific Research (C) #24K13494. SK, HS, and DWD have no financial disclosures to declare.
